SPECTRUM PHARMACEUTICALS INC·4

Apr 5, 5:42 PM ET

LEBEL FRANCOIS 4

4 · SPECTRUM PHARMACEUTICALS INC · Filed Apr 5, 2022

Insider Transaction Report

Form 4
Period: 2022-04-04
LEBEL FRANCOIS
Chief Medical Officer
Transactions
  • Sale

    Common Stock, $0.001 par value

    2022-04-04$1.35/sh1,205$1,627253,880 total
  • Sale

    Common Stock, $0.001 par value

    2022-04-05$1.41/sh1,367$1,927252,513 total
Holdings
  • Common Stock, $0.001 par value

    (indirect: By 401(k))
    7,226
Footnotes (1)
  • [F1]All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION